Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Cronobacter"


9 mentions found


Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. The FDA pulled up these companies for failing to establish processes to ensure infant formula does not become contaminated during manufacturing. The recalls were meant to remove products potentially contaminated with the bacteria cronobacter sakazakii, the FDA added. "The agency... believes that the recalls were effective in removing the potentially contaminated batches of product from the market," the FDA said. Infant formula manufacturing is under greater scrutiny following the shortage of the product last year due to a shutdown of Abbott Laboratories' (ABT.N) unit in Michigan.
Persons: Andrew Kelly, Benckiser, Mead Johnson, Perrigo, ByHeart, Leroy Leo, Krishna Chandra Organizations: Food and Drug Administration, FDA, REUTERS, U.S . Food, Drug Administration, ByHeart Inc, Mead Johnson Nutrition, Abbott Laboratories, Thomson Locations: White Oak , Maryland, U.S, PRGO.N, Wisconsin, Michigan, Bengaluru
Why some salads may be unsafe
  + stars: | 2023-08-03 | by ( Kirsi Goldynia | ) edition.cnn.com   time to read: +16 min
Even harder to contend with is the fact that the food products most susceptible to contamination are often those we eat for their health benefits – produce items. “Produce led the list; about 46% of the foodborne illness that we saw in the US could be attributable to produce. But you bring up a really great point that the processing of packaged meats may actually protect the products from pathogens. I think water is going to emerge as a huge issue. I think we’ve got systems in place that do a good job of making sure that consumers are getting good products.
Persons: Dr, Catherine Donnelly, Listeria, , Donnelly, “ Produce, ” That’s, , ” Donnelly, I’m, we’ve, Edwin Remsberg, they’re, there’s, Barack Obama’s, Bridget Bennett, Vibrio, Facebook There’s Organizations: CNN, Department of Nutrition, Food Sciences, University of Vermont, US Centers for Disease Control, CDC, , Food and Drug Administration, FDA, US Department of Agriculture, Getty, Bloomberg, Twitter, Facebook Locations: Western Washington, Cronobacter, Michigan, KFF, Vermont, hydroponics
Laura Modi wasn't looking for a reason to quit her job as she walked the aisles of her local pharmacy at 3 a.m. — she just wanted to find something to calm her crying newborn. Instead, hidden between a rack of magazines and discounted bottles of sunscreen, she found a multi-million dollar business idea: organic baby formula. It was 2016, and Modi had given birth to her daughter just five days earlier. In 2017, when Modi's daughter turned one, she decided to quit her job as Airbnb's head of hospitality and set out to create a baby formula with cleaner ingredients. In 2022, Bobbie's revenue topped $84 million, despite last year's nationwide shortage of baby formula, which was triggered by supply chain issues and the discovery of the life-threatening pathogen cronobacter in powdered formulas.
Persons: Laura Modi wasn't, Modi, wasn't, What's, Modi's, Bobbie, that's Locations: , San Francisco, U.S
A nationwide baby-formula shortage had some desperate parents driving hours in search of supplies. Dr. Steven Abrams, a pediatrician at the University of Texas at Austin, explained what parents should and shouldn’t do amid the crisis. Photo illustration: Laura KammermannIn a bid to help prevent another infant-formula crisis, U.S. health officials are expected to vote next month on a change designed to better warn of any uptick in bacterial infections in babies. The action would add infections from cronobacter, the bacteria that sickened four babies and fueled last year’s shortage, to a list of roughly 120 nationally notifiable diseases. Federal officials believe that designation will more quickly alert them to possible outbreaks and gather more information, including genetic data, to help them better understand and prevent the infections.
The U.S. supply of infant formula industry is still vulnerable to safety issues and supply disruptions more than a year after a nationwide shortage that left parents scrambling to feed their children, a former Food and Drug Administration official told U.S. lawmakers on Tuesday. The FDA announced a nationwide recall on that day of Abbott Nutrition 's popular Similac, Alimentum and EleCare baby formulas that sparked the nationwide shortage. The infant formula was recalled after several infants became sick with bacterial infections and two died. The plant was shuttered for months, sharply reducing formula supply across the U.S. He pointed to structural and cultural issues within the agency, a failure to monitor the food supply chain and inadequate public health surveillance of the fatal bacteria, Cronobacter sakazakii, that contaminated Abbott's formula.
Abbott Laboratories is under investigation by the U.S. Department of Justice, the company confirmed Friday, almost a year after it shut down a Michigan baby-formula plant after illnesses were reported. Abbott did not specify what aspect of the company is under Justice Department scrutiny. “DOJ has informed us of its investigation and we’re cooperating fully,” an Abbott spokesperson said in a statement to NBC News. The Abbott manufacturing facility in Sturgis, Mich., on May 13, 2022. Abbott voluntarily shut down production at its Sturgis infant formula manufacturing plant on Feb. 17, 2022, after infants who consumed formula made at the plant became sick.
CNN —The US Food and Drug Administration is charting a plan to enhance its surveillance of infant formula for Cronobacter bacteria. Cronobacter infections are rare, but they can be serious and even fatal, especially in newborns. Cronobacter lives in the environment, but when these infections are diagnosed in infants, they are often linked to powdered formula. Only one state, Minnesota, now requires doctors to report Cronobacter infections to the state health department. The infants had all consumed powdered formula manufactured at an Abbott Nutrition production facility in Sturgis, Michigan.
Nov 15 (Reuters) - The U.S. health regulator said on Tuesday it would review guidance and rules about manufacturing infant formula as part of its strategy to prevent bacterial illness similar to Abbott Laboratories' (ABT.N) products this year. The plant shutdown and the recall of Abbott infant formula products deepened a supply shortage and sent parents in the United States scrambling. Abbott's plant was restarted in July. While the bacterial infection is considered rare and is not reportable in most states, it can be deadly in newborns. Abbott's products were recalled following reports of four cases and two deaths.
WASHINGTON — The Food and Drug Administration acknowledged Tuesday that its response to the U.S. infant formula shortage was slowed by delays in processing a whistleblower complaint and test samples from the nation’s largest formula factory. It comes nearly eight months after the FDA shuttered Abbott’s Michigan plant due to safety concerns, quickly slashing domestic production within the highly concentrated formula industry. The FDA also faced challenges ramping up its testing capacity for cronobacter, a rare but potentially deadly bacteria repeatedly linked to outbreaks in baby formula. U.S. inventories of baby formula have been improving, hitting in-stock rates above 80% last week, according to IRI, a market research firm. That review is being led by former FDA commissioner Dr. Jane Henney, who led the agency during the final years of the Clinton administration.
Total: 9